Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Bours

Showing results (41-50 of 199) with videos related to

Pageof 20
Sort By:
Oncoimmunology|September 14, 2020
Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapseConcetta Elisa Onesti, Claire Josse, Delphine Boulet, et al.
Oncogene|February 27, 2004
Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2Valérie Benoit, Biserka Relic, Xavier de Leval Xd, et al.
Oncotarget|September 29, 2018
Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatmentConcetta Elisa Onesti, Claire Josse, Aurélie Poncin, et al.
Cancer Research|April 17, 2004
Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor alpha stimulation is counteracted by nuclear factor kappaB through c-FLIP-L expressionValérie Benoit, Alain Chariot, Laurence Delacroix, et al.
International Journal of Oncology|June 18, 2004
Modulation of the HSV-TK/ganciclovir bystander effect by n-butyrate in glioblastoma: correlation with gap-junction intercellular communicationPierre A Robe, Olivier Jolois, Minh N'Guyen, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2020
ROHHAD(NET) Syndrome: Systematic Review of the Clinical Timeline and Recommendations for Diagnosis and PrognosisJulie Harvengt, Caroline Gernay, Meriem Mastouri, et al.
Frontiers in Genetics|April 10, 2026
Genetic aetiology of global developmental delay and intellectual disability in Africa: a scoping reviewNorbert Dukuze, Janvier Hitayezu, Jeanne P Uyisenga, et al.
Cancer Genetics and Cytogenetics|September 23, 2003
Deletion (6)(p22p25) is a recurrent anomaly of thymoma: report of a second case and review of the literatureChristian Herens, Marc Radermecker, Anne Servais, et al.
Briefings in Bioinformatics|July 11, 2025
Assessing Random Forest self-reproducibility for optimal short biomarker signature discoveryAhmed Debit, Christophe Poulet, Claire Josse, et al.
Therapeutic Advances in Medical Oncology|December 12, 2025
Targeting synthetic lethality: an effective therapeutic approach in ovarian and endometrial cancersAlizée Lebeau, Athanasios Kakkos, Natacha Leroi, et al.
Pageof 20

Showing results (41-50 of 199) with videos related to

Sort By:
Pageof 20
Oncoimmunology|September 14, 2020
Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapseConcetta Elisa Onesti, Claire Josse, Delphine Boulet, et al.
Oncogene|February 27, 2004
Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2Valérie Benoit, Biserka Relic, Xavier de Leval Xd, et al.
Oncotarget|September 29, 2018
Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatmentConcetta Elisa Onesti, Claire Josse, Aurélie Poncin, et al.
Cancer Research|April 17, 2004
Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor alpha stimulation is counteracted by nuclear factor kappaB through c-FLIP-L expressionValérie Benoit, Alain Chariot, Laurence Delacroix, et al.
International Journal of Oncology|June 18, 2004
Modulation of the HSV-TK/ganciclovir bystander effect by n-butyrate in glioblastoma: correlation with gap-junction intercellular communicationPierre A Robe, Olivier Jolois, Minh N'Guyen, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2020
ROHHAD(NET) Syndrome: Systematic Review of the Clinical Timeline and Recommendations for Diagnosis and PrognosisJulie Harvengt, Caroline Gernay, Meriem Mastouri, et al.
Frontiers in Genetics|April 10, 2026
Genetic aetiology of global developmental delay and intellectual disability in Africa: a scoping reviewNorbert Dukuze, Janvier Hitayezu, Jeanne P Uyisenga, et al.
Cancer Genetics and Cytogenetics|September 23, 2003
Deletion (6)(p22p25) is a recurrent anomaly of thymoma: report of a second case and review of the literatureChristian Herens, Marc Radermecker, Anne Servais, et al.
Briefings in Bioinformatics|July 11, 2025
Assessing Random Forest self-reproducibility for optimal short biomarker signature discoveryAhmed Debit, Christophe Poulet, Claire Josse, et al.
Therapeutic Advances in Medical Oncology|December 12, 2025
Targeting synthetic lethality: an effective therapeutic approach in ovarian and endometrial cancersAlizée Lebeau, Athanasios Kakkos, Natacha Leroi, et al.
Pageof 20